Peptic Ulcer Disease 2011
DOI: 10.5772/22090
|View full text |Cite
|
Sign up to set email alerts
|

Conventional and Novel Pharmaceutical Dosage Forms on Prevention of Gastric Ulcers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 130 publications
0
4
0
1
Order By: Relevance
“…The water soluble hydrophilic polymers such as Na CMC hydrate rapidly and create pores. These pores are filled with the solvent, which distributes within the microbeads and thus accelerates the erosion of the gel layer (33).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The water soluble hydrophilic polymers such as Na CMC hydrate rapidly and create pores. These pores are filled with the solvent, which distributes within the microbeads and thus accelerates the erosion of the gel layer (33).…”
Section: Discussionmentioning
confidence: 99%
“…However, in the case of F 1 microbeads, the drug release was lesser (85.52%) than that of the F 3 microbeads (103.74%). Na CMC as a polymer indicates poor release prolonged result owing to the presence of wide amount of hydroxyl groups, which guides to extremely swollen matrix and causes loose gel layer formation, pursued by erosion, if reportedly due to the weakening of the CMC hydrogel matrix (33). During dissolution, the formulations prepared using Na CMC as a polymer were swelled making a gel layer on the represented surface of microbeads.…”
Section: Discussionmentioning
confidence: 99%
“…Međutim, kod preparata NSAIL koji ispoljavaju sistemsko delovanje, incidenca neželjenih dejstava je visoka, čak i u slučajevima primene pomenutih inovativnih formulacija. Takođe, neke lekovite supstance primenjene oralnim putem podležu metabolizmu prvog prolaza, čime se smanjuje efektivna koncentracija leka u plazmi (4,6,7,52).…”
Section: Prednosti I Ograničenja Savremenih Farmaceutskih Oblika Nsailunclassified
“…When administered orally, side effects such as gastric-duodenal ulcers and its short half-life are problems in clinical. Various strategies have been explored to avoid NSAIDs related toxicity, including concomitant administration of gastric protectors [4] use of rectal drug delivery systems [5], or modified release formulations [6]. The development of oral controlled and sustained release offers a potential benefit for NSAIDs.…”
Section: Introductionmentioning
confidence: 99%